David Freedman

Who declines neurocognitive testing? A cross-sectional study in people with multiple sclerosis

In 334 people with multiple sclerosis, a backward stepwise regression analysis was conducted to identify clinical characteristics that predict who declines neurocognitive testing ( p < 0.05), from demographics, disease-related variables, psychiatric diagnoses, and self-reported c...